"Balanced Biotech Strategy"
Updated
Trading TNXP requires careful consideration of both the high reward potential and the significant risks involved. Combining technical analysis for short-term trades with a fundamental approach for long-term investments, while employing robust risk management techniques, can help navigate the volatile nature of this stock. Always stay informed about the latest company developments and market conditions to make well-informed decisions.
Trade active
Note
I started investing in this stock before its split in January 2023, with a consistent accumulation strategy that brought my average cost to 16 cents. Leveraging thorough technical analysis, extensive research, and a personal connection to the company, I identified its long-term potential early on.
Recently, I took profits at $1.90 while maintaining a core position for the long term. This approach balances steady growth with strategic profit-taking, reflecting my confidence in the company's trajectory.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.